Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

PROCENTRA 5 MG/5 ML SOLUTION

dextroamphetamine sulfate
$1.6232per ML
DEA Schedule CII

Strength

5 mg/5mL

Manufacturer

INDEPENDENCE PHARMACEUTICALS, LLC

NDC

21724070105

Classification

Brand (ANDA)

Dosage Form

SOLUTION

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DEXTROAMPHETAMINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA040776

On Market Since

5/15/2014

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

0.0%

3M

-0.0%

6M

+0.2%

1Y

-0.2%

3Y

-1.0%

5Y

-1.0%

All

+8.3%

Generic Alternatives

Save up to 29%

1 alternative • Same active ingredient

DEXTROAMPHETAMINE 5 MG/5 ML
Generic
66993035957•Prasco Laboratories
$1.1454
Save 29%

Related Drugs

Same classification

ZENZEDI 20 MG TABLET
Brand
24338085503•Azurity Pharmaceuticals Inc.
$7.0423
per EA
EVEKEO 10 MG TABLET
Brand
24338002603•Azurity Pharmaceuticals Inc.
$7.6897
per EA
FIORICET 50-300-40 MG CAPSULE
Brand
52544008001•Actavis Pharma, Inc.
$8.8237
per EA
ZENZEDI 30 MG TABLET
Brand
24338085603•Azurity Pharmaceuticals Inc.
$10.4026
per EA
ADDERALL 20 MG TABLET
Brand
57844012001•Teva Pharmaceuticals USA Inc.
$12.1989
per EA
ADDERALL 10 MG TABLET
Brand
57844011001•Teva Pharmaceuticals USA Inc.
$12.2247
per EA
ADDERALL 30 MG TABLET
Brand
57844013001•Teva Pharmaceuticals USA Inc.
$12.2276
per EA
ADDERALL 5 MG TABLET
Brand
57844010501•Teva Pharmaceuticals USA Inc.
$12.2426
per EA
ADDERALL 15 MG TABLET
Brand
57844011501•Teva Pharmaceuticals USA Inc.
$12.3115
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy